Trial intelligence / Profile preview

Balloon dilatation versus methotrexate for post-intubation tracheal stenosis

IRCT20170531034256N3Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Mar 2019
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial of methotrexate in tracheal stenosis (TS) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Length of stenosed section and Severity of stenosis. Started Mar 2019; status: completed.

02

Drugs

methotrexate
03

Conditions

tracheal stenosis (TS)

Beyond the preview

Go deeper on IRCT20170531034256N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20170531034256N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call